Stockreport

Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence [Seeking Alpha]

Exagen Inc.  (XGN) 
Last exagen inc. earnings: 3/25 04:05 pm Check Earnings Report
PDF CEO John Aballi emphasized Exagen's commitment to addressing diagnostic delays in autoimmune diseases, stating the company is “working to own the entire space, providin [Read more]